Bexxar tositumomab: Began Phase II trial

Separately, the partners completed enrollment in a Phase II trial of Bexxar as first-line treatment of low-grade NHL in combination with fludarabine chemotherapy (see BioCentury, Dec. 13, 1999).

The partners are preparing a BLA submission for Bexxar as a single agent to treat relapsed or refractory low-grade NHL. ...